Rheumatism is a common self-immunological disease, which, in addition to the symptoms of the joints, may be burdened with multiple organs, of which pulmonary hysterectomy is one of the more severe lung manifestations. Understanding the need for attention to changes in pulmonary arthritis arthritis is essential for the health management of patients.
I. Pneumonia associated with rheumatism can occur in any part of the lungs in different sizes, numbers and forms. It may exist in isolation or in parallel. In visual examinations (e.g. chest X-lines, CT, etc.), the pulmonary knots are rounded or typed shadings of the lung, and the density may be even or uneven. The formation of these knots is closely related to the immune response in patients with rheumatism. As a result of immune system disorders, immunosuppressants are deposited in the lungs, stimulating inflammation of lung tissues, which in turn leads to the formation of pulmonary knots.
Symptoms performance and monitoring However, as the number of knots increases or increases, some respiratory symptoms may gradually occur. Common symptoms include cough, which may initially be occasional dry cough, which may be exacerbated if the knot irritates the bronchial or co-infection, accompanied by cough, and the nature of the siplet, which may vary from case to case, e.g., white slime, yellow sepsis, etc. Respiratory difficulties may also occur, especially after the activity, as the pulmonary knot affects the normal gas exchange function of the lung. chest pain is also one of the possible symptoms, which can cause diarrhea or sting in the chest when constricted and plebras, and the degree and nature of pain varies from one individual to another. Thus, patients with rheumatological arthritis should undergo regular pulmonary visual examinations, such as a CT examination at least once a year, even if they are not suffering from symptoms, in order to detect changes in pulmonary knots in time. In cases where pulmonary knots have been detected, the size, nature and doctor ‘ s recommendation may require a shorter interval between examinations, close monitoring of the growth rate of the nodal, morphological changes and whether new nodals have occurred.
III. Identification of other pulmonary diseases For example, tuberculosis can also be seen as a change in the pulmonary choreography, but tuberculosis patients are often associated with symptoms of all-body tuberculosis poisoning, such as low heat, sweat theft, inactivity and wasting, with fungus of tuberculosis found in the sluice, and a test of tuberculosis fungus (PPD) or a test of gamma-fouling (e.g. T-SPOT.TB) is often positive. Lung tumours are also diseases requiring priority identification, especially lung cancer. The pulmonary knots of patients with lung cancer tend to have a number of characteristic manifestations, such as irregularity at the edge of the knot, stings, foliage and faster growth. CT, oncological markers (e.g., cancer embryo antigen CEA, neuronspecific ethanolase NSE, etc.) and bronchoscopy or pulmonary pulmonary puncture detection help to identify rheumatism pulmonary tumours. In addition, diseases such as inflammation of the lung, fungi pneumonia, etc. may have a similar pulmonary hysterectomy, requiring careful identification by a doctor of the patient ‘ s history, symptoms, signs and results of various examinations to develop the correct treatment.
Treatment and management For the treatment of rheumatism pulmonary arthritis, the active control of rheumatitis is the first. By regulating the immune system through the use of improved rheumatizers (DMARDs), such as ammonium butterflies and fluoromethers, it is possible to discourage the further development of pulmonary knots. The adverse effects of the drugs, especially on the lungs, need to be closely monitored in the use of these drugs, as some DMARDs may cause adverse effects on the lungs, such as ammonium pyrochlorine, which may cause inter-pulmonary fibrosis. Some patients with more serious conditions, high lung dysentery or a tendency to undergo a degenerative state may need to be treated with biological agents. Biological agents can more accurately target inflammation factors and quickly and effectively reduce the immune response, but there are also risks associated with the use of biological agents, such as increased risk of infection, which need to be closely assessed and monitored by doctors. In addition, patients with apparent respiratory symptoms, such as cough, cough, respiratory difficulties, etc. can be treated accordingly. Coughing can be used in cases of severe coughing, tacting can be used in cases where the cough is weak, and support treatments such as oxygen use can be given to people with respiratory difficulties. In their daily lives, patients are also required to take care of their lungs, to stop smoking and alcohol, to avoid inhaling harmful gases and dust, to improve their nutrition, to exercise properly, to improve their health and to improve their immunity in order to promote their lung health.
When pulmonary hysteria changes occur in patients with rheumatism, high priority needs to be given to working closely with doctors for comprehensive examinations, accurate diagnosis, active treatment and long-term monitoring. Only in this way can changes in conditions be detected in a timely manner and effective measures taken to minimize the health effects of pulmonary knots, to improve the quality of life and to fight effectively against rheumatism and its lung complications.
